Resources

For companies marketing medicines in the European Union, the Pharmacovigilance System Master File (PSMF) is a core regulatory requirement. The document provides regulators with a detailed overview of the pharmacovigilance system used by the marketing authorisation holder (MAH). Despite being mandatory, many companies struggle with how to structure the PSMF and how detailed it needs to be. This article explains the purpose of the PSMF, its regulatory background, and how compan

For pharmaceutical and biotech companies entering or operating in the European market, pharmacovigilance (PV) is a critical regulatory requirement. A well-structured pharmacovigilance system ensures that the safety of medicinal products is continuously monitored once they are on the market. However, many companies especially startups or companies new to Europe are unsure how extensive their PV obligations are and how to implement them efficiently. This article provides an ove

In a time when biotech and medtech are moving faster than ever, one thing has barely changed in the last 20 years: documentation. SOPs, procedures, templates, and log forms form a foundation that should ensure consistency and compliance. But in many companies, it has instead become a bottleneck that slows progress and drains resources. An Invisible Bottleneck No One Talks About Ask startup founders and QA professionals behind closed doors, and the message is the same: Documen

Learn how to implement a Quality Management System without bureaucracy. A step-by-step guide for biotech and life science companies using te

Learn how to achieve inspection readiness with OZQA’s QMS templates and implementation services. A practical guide for biotech and life scie

Save time with fully written SOP templates for biotech. Fast implementation services and ongoing support membership to keep your documentation compliant and inspection-ready.

Build your QMS fast with fully written, pre-filled SOP templates from OZQA. Professionally developed, 90–99% complete, and ready for approva

Wondering if your biotech startup really needs a QMS? Discover why “too early” is never the right answer. From preclinical chaos to Phase III clarity, learn how a simple, scalable QMS can build investor trust, audit readiness, and peace of mind.

In the world of biotech and life science, the term GxP appears everywhere. It’s mentioned in every regulatory guideline, every partner contract, and every audit preparation checklist. Yet many organisations still struggle to translate GxP compliance into practical reality. What does GxP actually mean? Where should you start if you want to meet the requirements? And how can you build a system that works in daily operations and stands up to inspection? At OZQA, we help biotech

Learn how your biotech can achieve GxP compliance and FiH inspection readiness. OZQA provides turnkey QMS solutions tailored for biotech and

Let’s be honest. When you start a biotech company, you’re probably thinking about molecules, milestones and maybe money — not whether your SOPs are version-controlled or if your training logs are audit-proof. But somewhere between your first data set and your first patient dose, you realise: 👉 Quality isn’t optional. 👉 And compliance doesn’t care if you’re understaffed. To help you make sense of it all, we’ve broken down what “quality” really means — not in the abstract, bu

Why your team’s know-how doesn’t count unless you can prove it. You’ve hired smart people. Scientists with PhDs. Project managers with years of experience. People who actually read the SOPs (well, most of them). So you’d think your organisation is ready for inspection, right? Maybe. But let us ask you this: Can you prove that everyone has been trained on the latest version of the relevant SOPs? Can you show when they were trained? By whom? And on what? Can you demonstrate tha

Why sponsors still need a rock-solid QMS – even when everything is outsourced You’ve found a great CRO. The budget’s signed, the project plan is aligned, and your team can finally breathe. Or so you thought. Here’s the hard truth: outsourcing doesn’t outsource responsibility. Not in the eyes of regulators. As a sponsor, you are still expected to know what’s happening — and have the documentation to prove it. CRO ≠ Compliance Let’s be clear: we love CROs. They’re operational l

Running First-in-Human (FiH) trials isn’t just about hitting scientific milestones — it’s about doing it under tight timelines, limited resources, and a mountain of regulatory expectations. And somewhere between protocol drafts and CRO calls, compliance has to happen. But what does “compliance” actually mean at this stage? In our experience: clarity, structure, and a system that’s easy to live with. Preferably one that doesn’t live exclusively in someone’s inbox. A System You